1 August 2026 in Endocrine, Metabolic & Immune Disorders - Drug Targets
Introduction/Objective: Persistently elevated serum immunoglobulin M (IgM) is commonly interpreted as a marker of acute infection, autoimmune activity, or lymphoproliferation. Sustained IgM elevation may represent an underrecognized marker of underlying primary immunodeficiency disorders (PIDs), especially those associated with class-switch recombination defects or immune dysregulation. This article aims to highlight the diagnostic value of persistently elevated IgM levels in pediatric PIDs and to propose a practical clinical framework for the evaluation of children with unexplained IgM elevation. Methods: We performed a case-based narrative review of the literature on primary immunodeficiencies associated with elevated serum IgM, focusing on pathogenic mechanisms, clinical phenotypes, and diagnostic implications. The review was complemented by two pediatric cases from our practice in which persistent IgM elevation served as a clue to the diagnosis of distinct primary immunodeficiencies. Results: Persistently increased IgM levels in PIDs may reflect impaired class-switch recombination, impaired germinal center maturation, or chronic immune activation. The two presented cases, ataxiatelangiectasia with a hyper-IgM phenotype and BENTA disease, illustrate how elevated IgM associated with frequent and severe infections, lymphoproliferation, growth impairment, or syndromic features may guide clinicians toward immunological and genetic evaluation. Discussion: Persistent IgM elevation should be interpreted in its clinical context and should not be dismissed as a nonspecific laboratory abnormality. A structured diagnostic approach may help distinguish secondary causes, classic hyper-IgM syndromes, and hyper-IgM phenotypes. Conclusion: Persistently elevated serum IgM should not be dismissed as a transient abnormality in children with recurrent infections or immune dysregulation. When interpreted in its clinical context, it may serve as a practical indicator for further immunological investigation and diagnosis of PIDs.
1 March 2026 in Moldovan Journal of Health Sciences
Introduction. DiGeorge syndrome, known also as 22q11.2 deletion syndrome, is a rare multisystemic disorder characterized by a wide range of clinical features and may include thymic aplasia and subsequent immunodeficiency, conotruncal cardiac anomalies, typical facial features, palatal abnormalities, and hypocalcemia due to hypoparathyroidism. Material and methods. Data were collected for 10 patients genetically confirmed with DiGeorge syndrome at the Institute of Mother and Child. This included general information, laboratory results, and clinical features. Results. The mean age at diagnosis was 74.6 months (3 months - 28 years). Most cases were sporadic, with only 2 patients having a history of DGS (n=1), or close relatives with cardiac malformations (n=1). The most common symptoms that led to diagnosis were congenital heart defects (90%), and facial dysmorphism (90%). Common clinical features included recurrent infections (40%) and ENT disorders (20%). Weight was within normal percentiles for the entire group, but a delay in height growth was noted. Regarding the immunological characteristics: lymphopenia was recorded in 20% of patients, and thrombocytopenia in 2 patients. Conclusions. Given the diverse array of symptoms associated with DiGeorge syndrome, physicians should be knowledgeable about both typical and less common characteristics of the syndrome to facilitate optimal treatment and potentially enable early diagnosis.
1 December 2023 in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
Primary immunodeficiencies (PIDs) represent a heterogeneous group of congenital disorders, often associated with specific genetic mutations. They are characterized by a varied spectrum of clinical manifestations, malignant tumors being the second cause of death among patients with primary immunodeficiencies after infections. The article presents the clinical case of a 13-year-old patient with a history of severe ataxia, telangiectasias, frequent respiratory infections, and cervical and submandibular lymphadenopathy diagnosed with IDP Ataxia Telangiectasia based on ESID criteria. Against the background of IDP, he is also diagnosed with Non-Hodgkin’s lymphoma.